Terevalefim clinical trials
Also written ANG-3777.
How each study uses terevalefim is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2021 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Angion Biomedica Corp (4)
Studies
Open first, then newest update. How each study uses terevalefim is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Study to Prevent Acute Kidney Injury After Cardiac Surgery Involving Cardiopulmonary BypassStatus unknownPhase 2Angion Biomedica CorpNCT02771509Written as ANG-3777
- Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis SubjectsStatus unknownPhase 1Angion Biomedica CorpNCT04958187Written as ANG-3777
- Reduce the Severity of DGF in Recipients of a Deceased Donor KidneyStatus unknownPhase 3Angion Biomedica CorpNCT02474667Written as ANG-3777
- Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc IntervalStatus unknownPhase 1Angion Biomedica CorpNCT04898907Written as ANG-3777 (Therapeutic Dose)
As the comparator · 1 — what is tested is compared with terevalefim
Codes
What other systems call terevalefim · ClinicalTrials.gg INT001470
- MeSH (NLM) C000711731terevalefimOne source NLM
- UNII (FDA) GG91UXK2M5TEREVALEFIMConfirmed FDA, NLM
- NCI Thesaurus C175863TerevalefimOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000711731 | terevalefim | One source NLM |
| UNII (FDA) | GG91UXK2M5 | TEREVALEFIM | Confirmed FDA, NLM |
| NCI Thesaurus | C175863 | Terevalefim | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.